| HOME | 院長紹介 |

更新日 2017-11-18 | 作成日 2007-12-18

Mark1-1.png そうみやクリニック 
内分泌内科・代謝内科・糖尿病内科・内科 
Sohmiya Clinic, Endocrinology, Metabolism and Diabetes

院長紹介

氏名   宗宮 基 (そうみや もとい)
出身大学 島根医科大学(現 島根大学医学部) 昭和62年卒

資格等

 医学博士
 島根大学医学部 臨床教授

 日本内分泌学会認定 内分泌代謝科(内科)専門医
 日本糖尿病学会認定 糖尿病専門医  
           研修指導医
 日本内科学会認定  認定内科医 
           総合内科専門医

 日本内科学会  中国支部評議員
 日本内分泌学会 評議員

 米国内分泌学会員
 米国糖尿病学会員

 成長科学協会 成人成長ホルモン分泌不全症 地区委員

所属学会

 日本内分泌学会 
 日本糖尿病学会
 日本神経内分泌学会
 日本甲状腺学会
 日本内科学会

 米国内分泌学会
 米国糖尿病学会

専門ならびに研究分野

 内分泌代謝学
  汎下垂体機能低下症の治療
  成長ホルモンの補償療法
 糖尿病学
  糖尿病性腎症に伴う腎性貧血の治療

主な業績

主な著書・論文(日本語)

  1. 宗宮 基. 外来診療でのPOCTの実際 HbA1c. 医学書院 糖尿病診療マスター 9(2) 179-182, 2011.
  2. 宗宮 基. 糖尿病性腎症とエリスロポエチン. 科学評論社 内分泌・糖尿病科 20(3) 305-310, 2005.
  3. 宗宮 基, 金沢一平, 澄川美穂, 長戸 妙, 米原さなえ, 猪俣信子, 加藤 讓. 針無圧力注射器(ShimaJET)によりインスリン導入ができた針恐怖症の1例. 日本糖尿病学会 糖尿病 46(3):54-57, 2003.
  4. 宗宮 基, 加藤 讓. GH治療/新たな展開 Adult GHDへの治療.医学の世界社 ホルモンと臨床 48(5) 369-376, 2000.

主な著書・論文(英文)

  1. Sohmiya M, Sohmiya Y. Effects of recombinant human erythropoietin (rHuEPO) treatment on plasma insulin-like growth facor-I (IGF-I) and hemoglobin concentrations in patients with type 2 diabetes mellitus associated with nephropathy and anemia of chronic renal failure. Biomed Res. 2010 21(1):29-32.
  2. Sohmiya M, Kanazawa I, Kato Y. Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency. Eur J Endocrinol. 2005 Feb;152(2):211-5.
  3. Sohmiya M, Kato Y. Human growth hormone and insulin-like growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats. J Endocrinol. 2005 Jan;184(1):199-207.
  4. Nawata K, Sohmiya M, Kawaguchi M, Nishiki M, Kato Y.Increased resting metabolic rate in patients with type 2 diabetes mellitus accompanied by advanced diabetic nephropathy. Metabolism. 2004 Nov;53(11):1395-8.
  5. Sohmiya M, Kanazawa I, Inomata N, Yonehara S, Sumigawa M, Terai R, Shitamori A, Kagawa M, Kato Y.A new device to introduce self-injection of insulin by his non-dominant hand in a patient with hemiplegia. Diabetes Technol Ther. 2004 Aug;6(4):505-9.
  6. Sohmiya M, Kanazawa I, Kato Y. Seasonal changes in body composition and blood HbA1c levels without weight change in male patients with type 2 diabetes treated with insulin. Diabetes Care. 2004 May;27(5):1238-9.
  7. Sohmiya M, Nishiki M, Kato Y.Continuous subcutaneous infusion of recombinant human growth hormone (rhGH) improved renal function in a patient with Sheehan's syndrome associated with chronic renal failure. Endocr J. 1999 Mar;46 Suppl:S39-42.
  8. Sohmiya M, Kato Y. Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency. Clin Endocrinol (Oxf). 2001 Dec;55(6):749-54.
  9. Kato Y, Murakami Y, Sohmiya M, Nishiki M. Regulation of human growth hormone secretion and its disorders. Intern Med. 2002 Jan;41(1):7-13. Review.
  10. Sohmiya M, Kato Y. Molecular and electrical heterogeneity of circulating human erythropoietin measured by sensitive enzyme immunoassay. Eur J Clin Invest. 2000 Apr;30(4):344-9.
  11. Sohmiya M, Kato Y. Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism. J Endocrinol Invest. 2000 Jan;23(1):31-6.
  12. Sohmiya M, Kakiba T, Kato Y. Therapeutic use of continuous subcutaneous infusion of recombinant human erythropoietin in malnourished predialysis anemic patients with diabetic nephropathy. Eur J Endocrinol. 1998 Oct;139(4):367-70.
  13. Sohmiya M, Ishikawa K, Kato Y.Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failure. Eur J Endocrinol. 1998 Mar;138(3):302-6.
  14. Sohmiya M, Kato Y. [Fluctuations of physical function affected by sleep-awake rhythm--endocrine system] Nippon Rinsho. 1998 Feb;56(2):342-7. Review.
  15. Ishikawa K, Sohmiya M, Ohguni S, Sato T, Tanigawa K, Kato Y. Unique case of growth hormone (GH) deficiency accompanied by clinical anophthalmia, hypoplastic orbits, digital dysplasia, short stature, obesity, and diabetes mellitus. Am J Med Genet. 1996 Apr 9;67(2):191-6.
  16. Kato Y, Hu HY, Sohmiya M. Short-term treatment with different doses of human growth hormone in adult patients with growth hormone deficiency. Endocr J. 1996 Apr;43(2):177-83.
  17. Ishikawa K, Sohmiya M, Furuya H, Kato Y.A case of Sheehan's syndrome associated with severe anemia and empty sella proved 48 years after postpartum hemorrhage. Endocr J. 1995 Dec;42(6):803-9.
  18. Sohmiya M, Kato Y.Renal clearance, metabolic clearance rate, and half-life of human growth hormone in young and aged subjects. J Clin Endocrinol Metab. 1992 Dec;75(6):1487-90.